Xtant Medical

2015 Press Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014

Xtant™ Medical Announces First Surgical Procedure With the Aranax™ Cervical Plating System

12/15/15

BELGRADE, Mont., Dec. 15, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced the first surgical procedure of the previously annou...

Read More

Xtant™ Medical Announces First Surgical Case of Atrix-C™ Cervical Allograft Interbody Spacer

12/09/15

BELGRADE, Mont., Dec. 09, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced the first surgical case of the Atrix-C Cervical Allo...

Read More

Xtant™ Medical Announces the Global Launch for the Certex® OCT Spinal Fixation System

12/08/15

BELGRADE, Mont., Dec. 08, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, X-spine Systems, has r...

Read More

Xtant™ Medical To Present at ICV Manhattan Conference

12/03/15

BELGRADE, Mont., Dec. 03, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE:XTNT), formerly Bacterin International Holdings, Inc., a leader in the development of class-leading regenerative medicine products and medical devices, today anno...

Read More

Xtant™ Medical and Montana State University Develop Custom 3D Printer for Prototyping Reconstructive Implants

12/02/15

BELGRADE, Mont., Dec. 02, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, Bacterin Internati...

Read More

Xtant™ Medical Receives Clearance of Expanded Indication for Ilium Fixation and Deformity

12/01/15

BELGRADE, Mont., Dec. 01, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, X-spine Systems, Inc. ...

Read More

Xtant™ Medical To Present at the 8th Annual LD Micro Conference

11/24/15

BELGRADE, Mont., Nov. 24, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE:XTNT), formerly Bacterin International Holdings, Inc., a leader in the development of class-leading regenerative medicine products and medical devices, today anno...

Read More

Xtant Medical Holdings, Inc. Reports Third Quarter 2015 Results

11/11/15

Third Quarter 2015 Consolidated Pro Forma Highlights: Consolidated pro forma revenue increased 6.5% to $20.9 million from $19.6 million in the third quarter of 2014.  Excluding OEM revenue, third quarter 2015 consolidated pro forma revenu...

Read More

Xtant Medical Announces First Surgical Use of OsteoSelect® PLUS DBM Putty

11/03/15

BELGRADE, Mont., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced the first surgical implantation of OsteoSelect PLUS ...

Read More

Xtant Medical Holdings, Inc. to Report Third Quarter 2015 Financial Results on November 11, 2015

11/02/15

BELGRADE, Mont., Nov. 02, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results for the perio...

Read More

Xtant Medical Holdings Begins Trading on NYSE MKT Under Symbol "XTNT"

10/19/15

BELGRADE, Mont., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSEMKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that its common stock will begin trading today on the...

Read More

Xtant Medical Holdings Announces Uplisting to NYSE MKT

10/15/15

BELGRADE, Mont., Oct. 15, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (BONE), a leader in the development of regenerative medicine products and medical devices, today announced that its common stock has been approved for listing on the NY...

Read More

Xtant Announces Preliminary Third Quarter 2015 Revenue

10/13/15

Third Quarter 2015 Pro Forma Combined Revenue in the range of $20.7 million to $20.9 million, an increase of 5.5 % to 6.5 % over the same period last year Excluding OEM Revenue, Third Quarter 2015 Pro Forma Combined Revenue expected to increase ...

Read More

Xtant(TM) Medical Exhibits at North American Spine Society (NASS) Meeting

10/12/15

BELGRADE, Mont., Oct. 12, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiaries, X-spine Systems Inc...

Read More

Xtant(TM) Medical Awarded Grant From the Montana Board of Research and Commercialization Technology

10/06/15

BELGRADE, Mont., Oct. 06, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, Bacterin Internationa...

Read More

Xtant(TM) Medical Exhibits at the Congress of Neurological Surgeons Annual Meeting

09/28/15

BELGRADE, Mont., Sept. 28, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiaries, X-spine Systems and ...

Read More

Xtant(R) Medical Announces Expanded Patent Coverage of Core Technologies

09/22/15

BELGRADE, Mont., Sept. 22, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, Bacterin International...

Read More

Xtant Medical Announces FDA Clearance of the Aranax™ Cervical Plate

09/09/15

BELGRADE, Mont., Sept. 9, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, X-spine Systems, receiv...

Read More

Xtant Medical to Exhibit at EUROSPINE 2015

09/01/15

BELGRADE, Mont., Sept. 1, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, X-spine Systems, Inc., ...

Read More

Xtant Medical to Present at the Rodman Renshaw 17th Annual Global Investment Conference

08/27/15

BELGRADE, Mont., Aug. 27, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), formerly Bacterin International Holdings, Inc., a leader in the development of class-leading regenerative medicine products and medical devices, today annou...

Read More

Xtant Medical Announces FDA Approval of OsteoSelect(R) PLUS

08/25/15

BELGRADE, Mont., Aug. 25, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, Bacterin International,...

Read More

Xtant Medical Reports First Half 2015 Financial Results

08/12/15

First Half Xtant(TM) Medical Pro Forma Combined 2015 Highlights: On July 31, 2015, the Company announced the close of its acquisition of X-spine Systems, Inc. Pro forma combined revenue increased 12.6% to $43.4 million from $38.5 millio...

Read More

Xtant Medical Holdings, Inc. to Report Second Quarter 2015 Financial Results on August 12, 2015

08/04/15

BELGRADE, Mont., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (BONE), a leader in the development of revolutionary bone graft material, today announced that it will release its financial results for the period ended June 30, 2015, at...

Read More

Bacterin International Holdings Closes Offering of $65 Million of 6.00% Convertible Senior Notes

07/31/15

BELGRADE, Mont., July 31, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, has announced the closing of its previously announced offering of $65 million agg...

Read More

Bacterin Closes Purchase of the Outstanding Common Stock of X-spine Systems, Inc.

07/31/15

Combines Bacterin's Strength in Orthobiologics With X-spine's Expertise in Hardware Offering Complementary Product Lines Focused on Orthopedic and Spine Surgical Procedures BELGRADE, Mont., July 31, 2015 (GLOBE NEWSWIRE) -- Bacterin International Ho...

Read More

Bacterin International Holdings Prices $65 Million of 6.00% Convertible Senior Notes

07/27/15

BELGRADE, Mont., July 27, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, has announced the pricing of $65 million aggregate principal amount of convertibl...

Read More

Bacterin to Purchase the Outstanding Common Stock of X-spine Systems, Inc., Creating Xtant Medical

07/27/15

Combines Bacterin's strength in orthobiologics with X-spine's expertise in hardware offering complementary product lines focused on orthopedic and spine surgical procedures. Pro forma revenue and EBITDA for the combined company for the 12 mon...

Read More

Bacterin Announces Preliminary Second Quarter Revenue

07/09/15

Second Quarter Total Revenue in the Range of $10.0 Million to $10.2 Million, an Increase of Approximately 12-15% Over the Same Period Last Year. BELGRADE, Mont., July 9, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a ...

Read More

Bacterin International Holdings, Inc. Awarded Agreement With Premier, Inc.

06/24/15

BELGRADE, Mont., June 24, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE) has been awarded a new group purchasing agreement for the Bone Tissue Synthetic Implantable Products Category with Premier, Inc. Effective July 1st,...

Read More

Bacterin International Announces Signing of Agreement With Yankee Alliance

06/19/15

BELGRADE, Mont., June 19, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary biomaterials, today announced the signing of an agreement with Yankee Alliance, a group purchasing org...

Read More

Bacterin Announces the Launch of ArthroFuse(TM)

06/03/15

BELGRADE, Mont., June 3, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary biomaterials, today announced the release of ArthroFuse, a patent pending allograft specifically design...

Read More

CORRECTING AND REPLACING -- Bacterin Sets Annual Meeting and Record Dates

05/15/15

BELGRADE, Mont., May 15, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, has established a record date for its 2015 annual meeting of stockholders. Bac...

Read More

Bacterin Announces Record First Quarter 2015 Results

05/05/15

Company Continues to See Record Revenue Growth, Gross Profit Increases and Improved Gross Margins First Quarter Highlights: Total revenue increased 6.6% to $9.5 million from $8.9 million reported in first quarter of 2014 Gross profi...

Read More

Bacterin Sets Annual Meeting and Record Dates

05/04/15

BELGRADE, Mont., May 4, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, has established a record date for its 2015 annual meeting of stockholders. Bact...

Read More

Bacterin International Receives Coverage From Medicare Administrative Contractor (MAC) for hMatrix(R)

04/28/15

BELGRADE, Mont., April 28, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary allograft, today announced that its Acellular Dermal Matrix allograft (ADM), hMatrix®, has received c...

Read More

Bacterin to Report First Quarter 2015 Financial Results on May 5, 2015

04/23/15

BELGRADE, Mont., April 23, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, today announced that it will release its financial results for the period ended ...

Read More

Bacterin Announces Preliminary First Quarter 2015 Results

04/09/15

First Quarter Total Revenue Expected to be in the Range of $9.4 Million to $9.5 Million, an Increase of Approximately 5-7% Over the Same Period Last Year BELGRADE, Mont., April 9, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX...

Read More

Bacterin International to Begin Trading on OTCQX Marketplace

04/08/15

BELGRADE, Mont., April 8, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material, today announced that it received written notice from the staff at NYSE Regulat...

Read More

Bacterin Announces OsteoSponge(R) Patent

04/06/15

BELGRADE, Mont., April 6, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts, is pleased to announce that the United States Patent and Trademark Office has issued U...

Read More

Bacterin Announces Fourth Quarter and Year-End 2014 Results

03/17/15

Fourth Quarter Highlights: Total revenue increased to $9.1 million from $8.3 million in Q4 2013, an increase of 10.0% over the prior year Gross profit increased to $5.8 million compared to $4.1 million in Q4 2013, an increase of 41.2% o...

Read More

Bacterin Announces Contract Extension With Novation

03/16/15

BELGRADE, Mont., March 16, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material, today announced that it has extended its contract with Novation for an additional year. The...

Read More

Bacterin to Present at the Canaccord Genuity Musculoskeletal Conference

03/11/15

BELGRADE, Mont., March 11, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts, today announced that its CEO, Dan Goldberger, will present at the Canaccord Genuity M...

Read More

Bacterin Announces Distribution Agreement With Spartan Medical for DOD and VA Medical Centers

03/10/15

BELGRADE, Mont., March 10, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material, today announced it has signed a national distribution agreement with Spartan Medical, Inc.,...

Read More

Bacterin to Report Fourth Quarter 2014 Financial Results on March 17, 2015

03/02/15

BELGRADE, Mont., March 2, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material, today announced that it will release its financial results for the period and ...

Read More

Bacterin to Present at the 27th Annual ROTH Conference

02/24/15

BELGRADE, Mont., Feb. 24, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts, today announced that its CEO, Dan Goldberger, will present at the 27th Annual ROTH Con...

Read More

Bacterin Announces 1000th Lot of OsteoSelect(R) DBM Putty

02/17/15

BELGRADE, Mont., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced that it has eclipsed an operational mi...

Read More

Bacterin Announces Preliminary Fourth Quarter 2014 Revenue

01/12/15

Fourth Quarter Total Revenue in the Range of $8.9 Million to $9.1 Million, an Increase of Approximately 8-10% Over the Same Period Last Year BELGRADE, Mont., Jan. 12, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a ...

Read More